First international course on contrast enhanced ultrasound

Table of Contents

November 2008 6th – 9th Hanover, Germany

Like no other technique before, US contrast agents have revolutionized diagnostic ultrasound. In 2004, the European ultrasound societies developed guidelines on the use of US contrast agents in liver diseases. Although the main focus is still on liver diseases, it is accepted that US contrast agents can also add a great deal of diagnostic value in extra hepatic organ diseases, such as in renal diseases, which is now covered by the EFSUMB guidelines. These were updated in 2008 (www.efsumb.org).

I would very much like to encourage you to attend the first international course on contrast enhanced ultrasound (CEUS) in Hanover. It takes place November 6th–9th 2008 and is supported by the EFSUMB (Euroson School).

On the first day, the US manufactures and Bracco Company will present their current technology and give a lecture on their plans for the near future. Over the next three days the attendees will have the opportunity to learn about focal liver and renal diseases: each entity will first be reviewed by a pathologist and then CT, MRI and PET findings will be presented. This will be followed by the CEUS lectures. In the 'hands on' workshops the participants will be trained in small groups. Many well known experts in their diagnostic field both from inside and outside Europe have agreed to join the team.

CME credits can also be earned. You can find out more about this educational course as well as how to register by visiting our website: www.CEUS-course.eu.

Dr. HP Weskott, MD

On behalf of the International Faculty Board